Tech Company M&A Transactions
Alliant Pharmaceuticals Acquisition
Headquartered in Alpharetta, Alliant Pharmaceuticals was acquired by Sciele Pharma. The parties disclosed the acquisition price to be $109.8 million.
Transaction Overview
Company Name
Acquired By
Announced On
6/15/2007
Transaction Type
M&A
Amount
$109,750,000
M&A Terms
Sciele will pay approximately $109.75 million in cash for Alliant, which includes approximately $14 million in indebtedness.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
333 North Point Ctr. East 250
Alpharetta, GA 30022
USA
Alpharetta, GA 30022
USA
Phone
Website
Email Address
Not Recorded
Overview
Alliant Pharmaceuticals, Inc. is a Specialty Pharmaceutical Company focused on acquiring, developing and commercializing proprietary products for the pediatric and pediatric specialty markets. While a unique niche, the pediatric market is one of the fastest-growing pharmaceutical sectors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Pugh
Browse more venture capital transactions:
Prev: 6/15/2007: StackSafe venture capital transaction
Next: 6/18/2007: InCode BioPharmaceutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs